Allmed Medical Products Co., Ltd
SZSE:002950.SZ
9.17 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 863.059 | 830.169 | 741.806 | 732.313 | 591.568 | 612.076 | 814.642 | 1,143.341 | 932.733 | 1,141.389 | 993.039 | 598.302 | 830.658 | 676.013 | 820.582 | 745.753 | 833.22 | 1,657.967 | 597.558 | 640.889 | 616.897 | 580.567 | 514.109 | 579.756 | 545.582 | 495.787 | 406.387 | 438.072 |
Cost of Revenue
| 638.467 | 612.328 | 531.565 | 591.229 | 433.53 | 441.88 | 542 | 766.315 | 640.9 | 709.941 | 676.695 | 375.444 | 625.431 | 477.11 | 566.067 | 497.31 | 471.828 | 881.751 | 383.985 | 415.529 | 399.336 | 390.485 | 349.993 | 375.306 | 383.072 | 348.516 | 284.343 | 371.173 |
Gross Profit
| 224.592 | 217.841 | 210.242 | 141.084 | 158.038 | 170.196 | 272.642 | 377.027 | 291.834 | 431.448 | 316.344 | 222.859 | 205.227 | 198.903 | 254.515 | 248.443 | 361.392 | 776.216 | 213.573 | 225.36 | 217.561 | 190.082 | 164.116 | 204.45 | 162.51 | 147.271 | 122.044 | 66.899 |
Gross Profit Ratio
| 0.26 | 0.262 | 0.283 | 0.193 | 0.267 | 0.278 | 0.335 | 0.33 | 0.313 | 0.378 | 0.319 | 0.372 | 0.247 | 0.294 | 0.31 | 0.333 | 0.434 | 0.468 | 0.357 | 0.352 | 0.353 | 0.327 | 0.319 | 0.353 | 0.298 | 0.297 | 0.3 | 0.153 |
Reseach & Development Expenses
| 19.046 | 18.714 | 18.46 | 16.942 | 22.024 | 16.213 | 21.824 | 62.099 | 14.281 | 14.082 | 17.272 | 36.476 | 18.321 | 8.964 | 30.817 | 68.813 | 20.161 | 19.462 | 9.69 | 14.771 | 17.43 | 9.059 | 18.453 | 19.602 | 11.164 | 7.349 | 11.624 | 0 |
General & Administrative Expenses
| 0 | -37.839 | 65.033 | -193.839 | 218.481 | -56.097 | 90.81 | -205.776 | 234.98 | -33.492 | 102.927 | -152.985 | 185.981 | -39.591 | 72.778 | -125.608 | 59.834 | -25.485 | 52.467 | -99.478 | 55.487 | -24.694 | 48.303 | -82.372 | 42.241 | 41.365 | 37.758 | 0 |
Selling & Marketing Expenses
| 0 | 24.76 | 18.749 | 20.593 | 13.706 | 8.663 | 22.73 | 6.502 | 25.143 | 33.394 | 18.758 | 27.949 | 14.798 | 17.646 | 14.08 | -70.094 | 47.226 | 29.741 | 31.332 | 34.43 | 31.002 | 35.621 | 29.062 | 35.863 | 29.011 | 25.576 | 22.42 | 0 |
SG&A
| 104.849 | 81.251 | 83.071 | 75.504 | 232.187 | -47.434 | 113.54 | -199.275 | 260.123 | -0.098 | 121.685 | -125.036 | 200.779 | -21.946 | 86.858 | -195.703 | 107.06 | 4.257 | 83.799 | -65.049 | 86.488 | 10.927 | 77.365 | -46.509 | 71.252 | 66.941 | 60.177 | 0 |
Other Expenses
| -2.261 | 0.226 | -0.685 | -81.366 | 0.013 | 0.528 | -0.017 | 261.362 | -143.782 | 136.39 | -5.043 | 0.753 | -1.053 | -0.037 | -0.047 | 0.238 | -1.126 | 0.498 | -2.726 | 7.029 | -2.216 | 0.285 | -1.487 | -0.519 | -1.166 | 0.509 | -0.035 | 0 |
Operating Expenses
| 126.155 | 99.738 | 102.216 | 173.812 | 119.858 | 100.498 | 135.347 | 124.187 | 130.622 | 150.374 | 133.914 | 152.639 | 96.304 | 90.145 | 84.15 | 43.63 | 119.471 | 107.084 | 83.453 | 113.987 | 90.292 | 85.043 | 92.294 | 93.1 | 79.482 | 74.411 | 73.694 | 0.146 |
Operating Income
| 98.437 | 118.102 | 108.026 | -32.728 | -0.004 | 47.628 | 149.456 | 257.895 | 20.918 | 159.257 | 196.322 | 104.73 | 108.103 | 148.413 | 144.628 | 213.795 | 299.158 | 722.118 | 106.711 | 123.12 | 127.236 | 70.605 | 69.583 | 100.768 | 71.292 | 54.454 | 51.081 | 66.899 |
Operating Income Ratio
| 0.114 | 0.142 | 0.146 | -0.045 | -0 | 0.078 | 0.183 | 0.226 | 0.022 | 0.14 | 0.198 | 0.175 | 0.13 | 0.22 | 0.176 | 0.287 | 0.359 | 0.436 | 0.179 | 0.192 | 0.206 | 0.122 | 0.135 | 0.174 | 0.131 | 0.11 | 0.126 | 0.153 |
Total Other Income Expenses Net
| 0.478 | 7.565 | 3.933 | -4.499 | 0.013 | 0.528 | -0.167 | -22.261 | -123.926 | -1.701 | -1.599 | 0.753 | -1.873 | 39.619 | -0.047 | 9.22 | 56.111 | 53.483 | -26.136 | 18.777 | -2.248 | -34.15 | -3.726 | -11.102 | -12.901 | -17.897 | 2.696 | 0.146 |
Income Before Tax
| 98.915 | 125.667 | 111.959 | -37.227 | 0.009 | 48.156 | 149.288 | 235.635 | -103.008 | 157.556 | 194.723 | 105.483 | 107.05 | 148.376 | 144.581 | 214.033 | 298.031 | 722.616 | 103.984 | 130.15 | 125.02 | 70.89 | 68.096 | 100.249 | 70.126 | 54.963 | 51.046 | 67.045 |
Income Before Tax Ratio
| 0.115 | 0.151 | 0.151 | -0.051 | 0 | 0.079 | 0.183 | 0.206 | -0.11 | 0.138 | 0.196 | 0.176 | 0.129 | 0.219 | 0.176 | 0.287 | 0.358 | 0.436 | 0.174 | 0.203 | 0.203 | 0.122 | 0.132 | 0.173 | 0.129 | 0.111 | 0.126 | 0.153 |
Income Tax Expense
| 16.921 | 27.366 | 20.535 | 12.468 | 9.822 | 20.15 | 22.384 | 27.735 | -9.749 | 26.416 | 35.854 | 4.39 | 16.18 | 25.715 | 27.245 | 14.289 | 48.779 | 101.637 | 13.497 | 22.647 | 19.101 | 14.938 | 13.272 | 14.134 | 16.139 | 9.243 | 10.558 | 13.276 |
Net Income
| 78.169 | 93.118 | 93.879 | -40.005 | -6.634 | 29.155 | 127.885 | 209.925 | -93.259 | 132.38 | 157.718 | 102.083 | 91.363 | 121.465 | 116.305 | 198.373 | 247.508 | 620.451 | 91.195 | 107.866 | 106.132 | 56.417 | 55.398 | 86.859 | 54.486 | 45.341 | 41.095 | 53.356 |
Net Income Ratio
| 0.091 | 0.112 | 0.127 | -0.055 | -0.011 | 0.048 | 0.157 | 0.184 | -0.1 | 0.116 | 0.159 | 0.171 | 0.11 | 0.18 | 0.142 | 0.266 | 0.297 | 0.374 | 0.153 | 0.168 | 0.172 | 0.097 | 0.108 | 0.15 | 0.1 | 0.091 | 0.101 | 0.122 |
EPS
| 0.13 | 0.15 | 0.15 | -0.063 | -0.011 | 0.046 | 0.2 | 0.33 | -0.15 | 0.21 | 0.25 | 0.16 | 0.14 | 0.19 | 0.18 | 0.31 | 0.39 | 0.98 | 0.14 | 0.17 | 0.25 | 0.096 | 0.095 | 0.15 | 0.097 | 0.081 | 0.073 | 0.094 |
EPS Diluted
| 0.13 | 0.15 | 0.15 | -0.063 | -0.011 | 0.046 | 0.2 | 0.33 | -0.15 | 0.21 | 0.25 | 0.16 | 0.14 | 0.19 | 0.18 | 0.31 | 0.39 | 0.98 | 0.14 | 0.17 | 0.25 | 0.096 | 0.095 | 0.15 | 0.097 | 0.081 | 0.073 | 0.094 |
EBITDA
| 105.25 | 176.161 | 127.708 | 25.673 | 16.387 | 68.44 | 104.798 | 159.862 | 25.901 | 211.31 | 193.882 | 113.508 | 110.415 | 142.025 | 159.227 | 209.683 | 269.304 | 705.239 | 131.308 | 104.912 | 160.225 | 101.789 | 73.514 | 136.486 | 109.176 | 65.296 | 58.999 | -0.267 |
EBITDA Ratio
| 0.122 | 0.212 | 0.172 | 0.035 | 0.028 | 0.112 | 0.129 | 0.14 | 0.028 | 0.185 | 0.195 | 0.19 | 0.133 | 0.21 | 0.194 | 0.281 | 0.323 | 0.425 | 0.22 | 0.164 | 0.26 | 0.175 | 0.143 | 0.235 | 0.2 | 0.132 | 0.145 | -0.001 |